Hinge Health, INC Form 4 insider transactions

James Budge, Chief Financial Officer of Hinge Health, Inc., sold 47,720 shares of common stock on October 12, 2026.

Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., sold 200,000 shares of common stock on October 12, 2026.

Daniel Antonio Perez, CEO & Co-Founder, a Director and 10% owner of Hinge Health, Inc., sold 4,100 shares of common stock on October 6, 2026 for $100.20 per share.

Tyler Sloat, a Director of Hinge Health, Inc., received 175 shares of common stock on October 5, 2026.

James Pursley, President of Hinge Health, Inc., reported a transaction in 831 shares of common stock on October 1, 2026.

James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction in 4,614 shares of common stock on October 1, 2026.

James Pursley, President of Hinge Health, Inc., sold 33,000 shares of common stock on September 21, 2026.

Elliott Robinson, a Director of Hinge Health, Inc., reported multiple transactions in common stock on September 14, 2026.

Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., sold 150,000 shares of common stock on September 14, 2026.

Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., sold 250,000 shares of common stock on September 11, 2026.

James Budge, Chief Financial Officer of Hinge Health, Inc., sold 55,561 shares of common stock on September 10, 2026.

Daniel Antonio Perez, CEO & Co-Founder, a Director and 10% owner of Hinge Health, Inc., sold 250,000 shares of common stock on September 10, 2026.

Elliott Robinson, a Director of Hinge Health, Inc., reported multiple transactions in common stock on September 9, 2026.

Elliott Robinson, a Director of Hinge Health, Inc., reported multiple transactions in common stock on September 4, 2026.

Elliott Robinson, a Director of Hinge Health, Inc., reported multiple transactions in common stock on September 2, 2026.

James Pursley, President of Hinge Health, Inc., reported a transaction in 6,326 shares of common stock on September 1, 2026.

James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction in 9,986 shares of common stock on September 1, 2026.

Elliott Robinson, a Director of Hinge Health, Inc., reported multiple transactions in common stock on August 25, 2026.

James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction in 11,563 shares of common stock on August 24, 2026.

James Pursley, President of Hinge Health, Inc., sold 33,000 shares of common stock on August 21, 2026.

Kristina M Leslie, a Director of Hinge Health, Inc., sold 1,200 shares of common stock on August 20, 2026 for $88.23 per share.

Elliott Robinson, a Director of Hinge Health, Inc., reported multiple transactions in common stock on August 19, 2026.

Teddie Benjamin Wardi, a Director of Hinge Health, Inc., reported a transaction in 4,637 shares of common stock on August 10, 2026.

Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., reported multiple transactions in common stock on August 4, 2026.

James Pursley, President of Hinge Health, Inc., reported a transaction in 831 shares of common stock on August 1, 2026.

James Budge, Chief Financial Officer of Hinge Health, Inc., reported a transaction in 4,614 shares of common stock on August 1, 2026.

Gabriel M.I. Mecklenburg, a Director of Hinge Health, Inc., received 944,250 shares of common stock on July 27, 2026.

Daniel Antonio Perez, CEO & Co-Founder, a Director and 10% owner of Hinge Health, Inc., reported multiple transactions in common stock on July 27, 2026.

Insight Holdings Group, LLC and affiliated entities reported significant transactions involving Hinge Health, Inc. (HNGE) Class A Common Stock, including conversions and sales.

Hinge Health Director Tyler Sloat acquired 246 shares of Class A Common Stock through the settlement of vested RSUs on July 5, 2026.